Respiri has announced that, along with partner Access Telehealth, it has successfully concluded a system integration of the companies’ platforms with the Michigan Children’s Hospital, the company’s first US customer. This includes Respiri’s proprietary wheezo device, application and health portal (which manages respiratory health data) along with Access Telehealth’s remote patient monitoring (RPM) platform, Remotli. Patient intake is expected to start in the coming weeks and would mark the first ....
01 Aug 2022
Respiri - Wheezo to begin patient use in the US
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Respiri - Wheezo to begin patient use in the US
Respiri Limited (RSH:ASX) | 0 0 3.0% | Mkt Cap: 29.5m
- Published:
01 Aug 2022 -
Author:
Soo Romanoff - Pages:
Respiri has announced that, along with partner Access Telehealth, it has successfully concluded a system integration of the companies’ platforms with the Michigan Children’s Hospital, the company’s first US customer. This includes Respiri’s proprietary wheezo device, application and health portal (which manages respiratory health data) along with Access Telehealth’s remote patient monitoring (RPM) platform, Remotli. Patient intake is expected to start in the coming weeks and would mark the first ....